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Copyright © 200? JCBN 200? This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. p59fyn, a protein tyrosine kinase belonging to the src family, is
involved in the regulatory mechanism of acute response to etha 
nol in the central nervous system. A previous report showed an
association between src family kinase activity and fatty acid oxi 
dation, and it also reported that hepatic free fatty acid levels
were low in Fyn−/− mice. We examined, using Fyn−/− mice
whether Fyn is also involved in fatty acid metabolism and the
development of pathological changes in the liver in response to
chronic ethanol consumption. C57BL/6J Fyn−/− and Fyn+/+ mice
were fed for 8 weeks with either a liquid diet comprising ethanol
or one in which the calories from ethanol were replaced with car 
bohydrates. Chronic ethanol consumption for 8 weeks resulted in
remarkable hepatic steatosis in Fyn+/+ mice but not in Fyn−/−
mice. Chronic ethanol consumption induced a significant decrease
in hepatic FFA and triglyceride levels in Fyn−/− mice. Levels of
interleukin 6, which is associated with the enhancement of fatty
acid oxidation, was also increased significantly in the livers of eth 
anol fed Fyn−/− mice. The results suggest that Fyn is involved in
the enhancement of fatty acid oxidation and the development of
hepatic steatosis caused by chronic ethanol consumption.
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Introduction P59fyn (Fyn) belongs to the src-family tyrosine kinase and is
ubiquitously expressed in various organs, most abundantly in
the immune system.(1) Fyn is known to play an important role in T
cell receptor-mediated apoptosis.(2–7)
Fyn has also been shown to be involved in the ethanol-mediated
acute response in the central nervous system.(8) Fyn−/− mice were
previously shown to be sensitive to hypnotic effects of ethanol,
and tyrosine phosphorylation of the hippocampal N-methyl-d-
aspartate (NMDA) type 2B receptor by Fyn plays an important
role in these effects.(8) In addition, Fyn−/− mice showed enhanced
fatty acid oxidation, and Fyn kinase activity was found to be
involved in the regulation of fatty acid oxidation.(9)
Ethanol is the most widely abused substance in the world.
Chronic alcoholism is known to cause pathological changes in
several organs, such as the liver, primarily because of disorders in
fatty acid oxidation in the liver.
Because Fyn has been reported to play an important role in
acute response to ethanol in the brain and to regulate fatty acid
oxidation in peripheral tissues under normal dietary conditions,
we examined the association of Fyn with the development of
hepatic steatosis induced by chronic ethanol consumption.
Materials and Methods
Animals. C57BL/6J Fyn−/− (Fyn−/−) mice were provided by
Jackson Laboratories (Bar Harbor, ME). This strain lacks the
normal expression of both brain- and lymphocyte-specific forms
of Fyn.(10) C57BL/6J Fyn+/+ (Fyn+/+) mice were obtained from
Japan SLC Co. Ltd. (Shizuoka, Japan). Age-matched 8-week-old
male mice were used for the experiments. They were housed in
plastic cages for 8 weeks on a 12-h light/12-h dark cycle under
controlled temperature (22 ± 1°C) and humidity (50 ± 10%).
Experimental designs. Mice were fed a liquid diet con-
taining ethanol (Lieber/DeCarli liquid diet-ethanol) or a liquid
diet in which the calories from ethanol were replaced with carbo-
hydrates (Lieber/DeCarli liquid diet-control), which was obtained
from Dyet Co. Ltd. (Bethlehem, PA). The mice were divided into
the following four experimental groups: (i) control-fed Fyn+/+
mice (n = 6), (ii) ethanol-fed Fyn+/+ mice (n = 6), (iii) control-fed
Fyn−/− mice (n = 6), and (iv) ethanol-fed Fyn−/− mice (n =6 ) .
All mice were fed for 8 weeks under this condition. Following
this, the mice were starved overnight, and their livers and bloods
were removed for further experiments. All experimental proce-
dures were performed in accordance with the Guide for the Care
and Use of Laboratory Animals (Osaka Medical College, Prefec-
ture, Japan). Each set of 8-week feeding experiments was carried
out twice.
Measurement of serum biochemical parameters. Levels
of serum aspartate aminotransferase (AST) and alanine amino-
transferase (ALT) were measured by a local laboratory for clinical
examinations (SRL Co. Ltd., Tokyo, Japan).
Measurement of hepatic biochemical parameters.
Hepatic tissues were homogenized using a Polytron homo-
genizer (ULTRA-TURRAX TP18/1051; Janke & Kunkel, IKA-
Labortechnik, Staufeni, Germany). Homogenization was done in a
buffer of pH 7.4 containing 20 mM Tris HCl, 1 mM EGTA, 2 mM
EDTA, and protease inhibitor cocktail containing leupeptin (2 μg/
mL). Hepatic tissue free fatty acid (FFA), triglyceride (TG), tumor
necrosis factor-α (TNF-α), and interleukin-6 (IL-6) levels were
measured by SRL Co. Ltd. (Tokyo, Japan).
Histological analysis. The livers were formalin-fixed, paraffin-
embedded, and processed for hematoxylin and eosin (H&E)
staining. Fatty changes in livers were classified into 4 grades:
<30% (0), 30–50% (1+), 50–70% (2+), and >70% (3+) hepatic
steatosis in lobules, as previously reported with some modifica-
tions.(11) Fatty deposits were verified by staining with Oil Red O
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(Sigma, City, Country).
Immunohistological analysis. For immunohistological anal-
ysis, the ABC staining kit (Vector Labs, Burlingame, CA) was
used in combination with anti-p59fyn antibody (Santa Cruz, CA).
Statistical analysis. The significance of differences between
values was analyzed using an unpaired Student’s t test, Kruskal-
Wallis test, and Mann-Whitney test. Differences were considered
significant at p<0.05.
Results
8- and 16-week-old male Fyn+/+ and Fyn−/− mice were divided
into four groups and fed a liquid diet-ethanol or a liquid diet-
control for 8 weeks: (i) control-fed Fyn+/+ mice (n = 6), (ii)
ethanol-fed Fyn+/+ mice (n = 6), (iii) control-fed Fyn−/− mice
(n = 6), and (iv) ethanol-fed Fyn−/− mice (n = 6).
Effect of treatments with liquid diets on body weight
and diet consumption. As shown Fig. 1, body weight of
control-fed mice was not significantly different at the end of the
experiment period (37.7 ± 4.4 and 34.8 ± 1.7 g in Fyn+/+ and
Fyn−/− mice, respectively; p<0.05). Body weight of ethanol-fed
mice was also not significantly different (28.0 ± 0.3 and 27.4 ±
1.4 g in Fyn+/+ and Fyn−/− mice, respectively; p<0.05). Signifi-
cant differences were observed between the two groups with
different diets but same genetic background (control-fed Fyn+/+
vs ethanol-fed Fyn+/+ mice; control-fed Fyn−/− vs ethanol-fed
Fyn−/− mice, respectively; p<0.05).
As shown in Tables 1 and 2, daily diet consumption by same
diet-fed mice was not significantly different (p<0.05).
Serum and hepatic biochemical parameters. To examine
whether the two diets induced liver damage and steatosis, we
quantified serum levels of AST and ALT and hepatic levels of
FFAs and TGs. Serum AST and ALT levels were significantly
higher in control-fed Fyn−/− mice than in control-fed Fyn+/+ mice
(p<0.05) (Table 1). In contrast, serum AST and ALT levels were
significantly higher in ethanol-fed Fyn+/+ mice than in ethanol-
fed Fyn−/− mice (p<0.05) (Table 2). Serum AST and ALT levels
were compared between the groups and were found to be signifi-
cantly higher in ethanol-fed Fyn+/+ mice (about 1.2–1.3 and 1.2–
1.9 times, respectively). Hepatic FFA and TG levels were signifi-
cantly higher in control-fed Fyn+/+ mice than in control-fed
Fyn−/− mice (p<0.05) (Table 1). In addition, hepatic FFA and TG
levels in ethanol-fed Fyn+/+ mice were significantly higher than
those in ethanol-fed Fyn−/− mice (p<0.05) (Table 2). Hepatic
FFA and TG levels were compared between the groups and were
Fig. 1. Effects of treatments with liquid diets on body weight. Data
are shown as the mean ± SD. ns: not significant.
Table 1. Diet consumptions and serum and hepatic biochemical para 
meters of the control fed Fyn+/+ and Fyn−/− mice
AST, aspartate aminotransferase; ALT, alanine aminotransferse; FFAs,
free fatty acids; TGs, triglycerides.
Statistical comparisons were made using Student’s t test.
Differences were considered significant when *p<0.05.
Fyn+/+ (n =6 ) F y n −/− (n =6 )
Diet consumption (cc/day) 10.0 ± 0.9 10.2 ± 1.0
AST (IU/L) 271.8 ± 6.0 286.4 ± 9.3*
ALT (IU/L) 49.1 ± 2.0 63.1 ± 3.8*
Hepatic FFAs (µEQ/L) 40.3 ± 1.3* 34.9 ± 1.9
Hepatic TGs (mg/dL) 40.8 ± 4.5* 29.3 ± 2.8
Table 2. Diet consumptions and serum and hepatic biochemical para 
meters of the ethanol fed Fyn+/+ and Fyn−/− mice
AST, aspartate aminotransferase; ALT, alanine aminotransferse; FFAs,
free fatty acids; TGs, triglycerides.
Statistical comparisons were made using Student’s t test.
Differences were considered significant when *p<0.05.
Fyn+/+ (n =6 ) F y n −/− (n =6 )
Diet consumption (cc/day) 6.0 ± 0.9 5.5 ± 0.9
AST (IU/L) 366.3 ± 8.9* 313.5 ± 7.6
ALT (IU/L) 91.9 ± 6.6* 77.9 ± 5.0
Hepatic FFA (μEQ/L) 56.7 ± 4.9* 24.8 ± 4.8
Hepatic TG (mg/dL) 156.3 ± 7.1* 15.3 ± 3.3
Fig. 2. Effects of a liquid diet containing ethanol or a liquid diet in
which the calories from ethanol were replaced with carbohydrates
(control) on the livers of Fyn+/+ and Fyn−/− mice. (A) Hematoxylin and
eosin staining (original magnification ×150). (B) Oil Red O staining
(original magnification ×150). Data are representative of two sets of
experiments. (a) control fed Fyn+/+ mice, (b) ethanol fed Fyn+/+ mice,
(c) control fed Fyn−/− mice, and (d) ethanol fed Fyn−/− mice.doi: 10.3164/jcbn.10 115
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found to be significantly higher in ethanol-fed Fyn+/+ mice (about
1.4–2.3 times and 3.8–10.2 times, respectively).
Histological analysis. Hepatic steatosis was distinctively
observed in the livers of ethanol-fed Fyn+/+ mice (Fig. 2 (A)).
In order to verify the existence of lipids, Oil Red O staining was
performed. Fatty droplets were fewer in control-fed Fyn−/− mice
when compared with control-fed Fyn+/+ mice (Fig. 2 (B) and
Table 3). The existence of fatty droplets was significantly greater
in ethanol-fed Fyn+/+ mice (p = 0.0012) than in the other groups.
In contrast, such changes were lesser in the livers of ethanol-fed
Fyn−/− mice (Fig. 2 (B) and Table 3).
Hepatic cytokine concentration. Levels of hepatic TNF-α
and IL-6 were found to be significantly higher in control-fed
Fyn−/− mice than in control-fed Fyn+/+ mice (p<0.05) (Fig. 3
(A)). Additionally, levels of hepatic TNF-α and IL-6 were found
to be significantly higher in ethanol-fed Fyn−/− mice than in
ethanol-fed Fyn+/+ mice (p<0.05) (Fig. 3 (B)). Consumption of
the liquid diet containing ethanol resulted in significantly greater
level of hepatic TNF-α in mice with the same genetic background
(432.4 ± 24.1 and 655.0 ± 17.5 pg/mL in control-fed and ethanol-
fed Fyn+/+ mice, respectively, and 563.2 ± 24.4 and 750.9 ± 21.7
pg/mL in control-fed and ethanol-fed Fyn−/− mice, respectively;
p<0.05) (Fig. 3 (A) and (B)). In addition, the liquid diet with
ethanol resulted in significantly greater levels of hepatic IL-6 in
mice with the same genetic background (25.7 ± 0.8 and 34.0 ± 2.2
pg/mL in control-fed and ethanol-fed Fyn+/+ mice, respectively,
and 46.7 ± 1.4 and 53.8 ± 2.0 pg/mL in control-fed and ethanol-
fed Fyn−/− mice, respectively; p<0.05) (Fig. 3 (A) and (B)).
Immunohistochemical analysis. The immunolocalization
of Fyn in the liver was examined by using the anti-Fyn antibody
and was markedly detected in hepatocytes (Fig. 4).
Discussion
Using C57BL/6J Fyn−/− and Fyn+/+ mice, we examined the
effects of chronic ethanol consumption in the liver. Histological
analysis of mice livers showed significant differences between
ethanol-fed Fyn−/− and Fyn+/+ mice. Conversely, no apparent
histological differences were observed in the livers of control-fed
Fyn−/− and Fyn+/+ mice. Remarkable hepatic steatosis was
observed in ethanol-fed Fyn+/+ mice, but not in ethanol-fed
Fyn−/− mice. Because of these histological differences, we
Table 3. Hepatic steatosis in mice
There was a significant difference (p = 0.0012) in the degree of hepatic
steatosis among 4 groups verified by the Kruskal Wallis test.
*Significantly different (p is equal to 0.0024, 0.0023, and 00019) from
control fed Fyn+/+, control fed Fyn−/−, and ethanol fed Fyn−/− mice,
respectively, by the Mann Whitney test.
Degree of hepatic steatosis
n 0 1 +2 +3 +
Control fed Fyn+/+ mice 63300
Ethanol fed Fyn+/+ mice* 60015
Control fed Fyn−/− m i c e64200
Ethanol fed Fyn−/− m i c e65100
Fig. 3. Levels of TNF α and IL 6 in the livers of Fyn+/+ (n = 6) or Fyn−/− (n = 6) mice. (A) Levels of hepatic TNF α and IL 6 were measured in control 
fed mice. Levels of hepatic TNF α and IL 6 increased significantly in the livers of control fed Fyn−/− mice. (B) Levels of hepatic TNF α and IL 6 were
measured in mice fed a liquid diet containing ethanol. Levels of hepatic TNF α and IL 6 increased significantly in the livers of ethanol fed Fyn−/−
mice. Data are shown as the mean ± SD (*p<0.05). J. Clin. Biochem. Nutr. | July 2011 | vol. 49 | no. 1 | 23
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examined possible differences in serum markers of liver injury.
Serum AST and ALT were significantly higher in ethanol-fed
Fyn+/+ mice than in ethanol-fed Fyn−/− mice.
Interestingly, chronic ethanol consumption induced a signifi-
cant decrease in the levels of hepatic FFAs and TGs in Fyn−/−
mice than in the Fyn+/+ mice. These results coincided with the
findings of the histological analysis of the livers of ethanol-fed
Fyn−/− mice. Bastie et al. showed that the levels of hepatic FFAs
and TGs were significantly decreased in Fyn−/− mice than in
Fyn+/+ mice under normal dietary consumption.(9) The results of
the present study concerning levels of hepatic FFAs and TGs in
control-fed Fyn−/− mice also coincided with their results. In this
study, the levels of hepatic FFAs and TGs were significantly lower
in ethanol-fed Fyn−/− mice than in control-fed Fyn−/− mice.
These results suggested that a Fyn deficiency was also involved in
an enhancement of fatty acid oxidation during ethanol metabolism.
It is well known that serum levels of the proinflammatory
cytokines TNF-α and IL-6 are elevated in alcoholics and in
animals fed ethanol chronically.(12–15) Another interesting finding
of this study was that the production of these proinflammatory
cytokines was significantly greater in the livers of ethanol-fed
Fyn−/− mice than in the livers of ethanol-fed Fyn+/+ mice. It
was of interest that the production of these cytokines in the liver
was also significantly different between control-fed Fyn−/− and
Fyn+/+ mice. These results suggest that Fyn is associated with
the regulation of hepatic TNF-α and IL-6 production.
Excess TNF-α production has shown to play an important role
in most forms of experimental liver disease.(15–17) In the present
study, the increase in the production of hepatic TNF-α in ethanol-
fed Fyn+/+ and Fyn−/− mice also coincided with the elevation of
serum AST and ALT markers of liver injury.
IL-6 has also been shown to play an important role in liver
regeneration, repair from injury, and antiapoptosis.(18–20) Hong et al.
reported that injection of IL-6 for 10 days prevented fatty liver
in ethanol-treated mice.(11) Furthermore, they reported that the
beneficial effect of IL-6 treatment was an increase in β-oxidation
of mitochondrial fatty acids.(11) In this study, ethanol-fed Fyn−/−
mice showed an increase in the production of hepatic IL-6 and did
not show the development of hepatic steatosis. Therefore, increase
in the production of IL-6 in the livers of Fyn−/− mice might be
due to enhanced fatty acid oxidation, resulting in inhibition of
histological changes due to chronic ethanol consumption. Despite
increased production of hepatic TNF-α in ethanol-fed Fyn−/−
mice when compared to that in ethanol-fed Fyn+/+ mice, the
elevation in serum AST and ALT levels in Fyn−/− mice was
inhibited when compared with levels in Fyn+/+ mice. Inhibition
of elevation in these serum parameters might have also been
associated with the increase in production of IL-6 in the liver of
Fyn−/− mice.
Because immunohistochemical analysis revealed the expression
of Fyn in hepatocytes, Fyn signaling in the cells may be strongly
associated with the mechanism responsible for greater ethanol
tolerance in Fyn−/− mice. Kupffer cells and hepatocytes produce
IL-6(21,22); therefore, the results of this study suggest that a Fyn
deficiency may, at least in part, increase IL-6 level in the liver.
Alcohol is the most common etiological factor for fat accumu-
lation in hepatocytes, which is also the earliest and most common
response to alcohol.(23,24) Therefore, inhibition of this response is
clinically important. We showed herein that chronic ethanol
consumption induced the enhancement of fatty acid oxidation as a
result of an increase in IL-6 production in the livers of Fyn−/−
mice, which resulted in the resistance to hepatic steatosis in these
mice. In conclusion, Fyn signaling might regulate the develop-
ment of hepatic steatosis due to chronic ethanol consumption.
Acknowledgments
The authors would like to thank Yukio Nakahira, at the Osaka
Medical College, for providing them with technical support.
Abbreviations
Fyn p59fyn
FFA Free Fatty Acid
TG Triglyceride
Fyn−/− C57BL/6J Fyn−/−
Fyn+/+ C57BL/6J Fyn+/+
AST Aspartate Aminotransferase
ALT Alanine Aminotransferase
TNF-α Tumor Necrosis Factor-α
IL-6 Interleukin-6
H&E Hematoxylin And Eosin
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